1Berggrdi, Beam AG. Isoiation and properties of a low molecu- lar weight β2 - MG occurring in human biological fluids J Bi- ol chem,1968,243(15) :4 095 -4 013.
10Fadela B, Jocelyne D, Jacques B, et al. Profiles and prognostic ues of serum LDH isoenzymes in patients with haematopoietic malignancies[J].Bulletindu Cancer,2004,91 : 10229-10240.
3Yang W, Lu J,Weng J, et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12): 1090-1010.
4Aksun SA,Ozmen D,Ozmen B,et al.z-microglobulin and cystatin C in type 2 diabetes:assessmet of diabetic nephropathy [J].Exp Clin Endocrinol Diabetes, 2004,112 (4) : 195-200.
5Wei L,Ye X,Pei X,et al.Reference intervals for serum cystatin C and factors influencing cystatin C levels other than renal function in the elderly[J].PLoS One,2014,9( 1 ): e86066.
6Lee BW,Ihm SH,Choi MG,et al.The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy[J].Diabetes Res Clin Pract, 2007, 78(3) :428-434.
7Shlipak MG,Samak MJ,Katz R,et al.Cystatin C and the risk of death and cardiovascular events among elderly persons [J].N Engl J Med, 2005,352(20 ) : 2049-2060.
8Yoo JS,Lee YM,Lee EH,et al.Serum cystatin C reflects the progress of albuminuria[J].Diabetes Metab J, 2011,35 (6) : 602- 609.
9Jeon YK,Kim MR,Huh JE,et al.Cystatin C as an earlybiomarker of nephropathy in patients with type 2 diabetes[J].J Korean Med Sci, 2011,26(2) : 258-263.
10Willems D, Wolff F, Mekahli F, et al.Cystatin C for early detection of renal impairment in diabetes [J].Clin Biochem, 2009,42 (1-2) : 108-110.
